Leaflet IRETIG 50mg prolonged-release tablets
- Product code:
- W70723001
- Quantity:
- 30
- Indicated for:
- overactive bladder; urinary incontinence
- Route of administration:
- oral
- Substance:
- mirabegron (beta-3 adrenergic agonist)
- ATC
- G04BD12 — Genito urinary system and sex hormones | Urologicals | Urologicals | Drugs for urinary frequency and incontinence
Mirabegrone is a medication used for the treatment of overactive bladder, characterized by symptoms such as frequent urination, urinary urgency, and urinary incontinence. It acts as a beta-3 adrenergic receptor agonist, relaxing the bladder muscles and increasing its capacity.
The medication is taken orally, usually once daily, and is effective in reducing symptoms associated with overactive bladder.
Side effects may include high blood pressure, urinary tract infections, headache, and nausea. It is important to monitor blood pressure during treatment.
Consult your doctor to discuss the benefits and risks of treatment with Mirabegrone. Follow the prescribed dosage and adhere to all medical recommendations.
The medication is taken orally, usually once daily, and is effective in reducing symptoms associated with overactive bladder.
Side effects may include high blood pressure, urinary tract infections, headache, and nausea. It is important to monitor blood pressure during treatment.
Consult your doctor to discuss the benefits and risks of treatment with Mirabegrone. Follow the prescribed dosage and adhere to all medical recommendations.
General data about IRETIG 50mg
- Substance:
- mirabegron
- Date of latest medicines list:
- 01-12-2024
- Product code:
- W70723001
- Concentration:
- 50mg
- Pharmaceutical form:
- prolonged-release tablets
- Quantity:
- 30
- Product type:
- Generic medicine
- Prescription status:
- P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Concentrations available for mirabegron
- 25mg
- 50mg